Capsugel Flexes Breadth Of Capabilities In Development Collaborations
This article was originally published in The Tan Sheet
Executive Summary
Amit Patel, president of Capsugel’s Dosage Form Solutions business unit, says the firm is able to work more closely with customers in the product development process since it is no longer a subsidiary of Pfizer. Capsugel announced the launch of its Lipidex integrated technology platform June 5.
You may also be interested in...
Capsugel Strives To Deliver Growth And Innovation Via New Unit, Execs
The oral dosage technology company has established a dosage form solutions business unit to help it diversify outside solid capsules. Capsugel also has hired a slate of executives to aid its final transition away from former parent company Pfizer.
Capsugel CEO Driesen Plots Post-Pfizer Course
Guido Driesen, president and CEO of Capsugel, says the oral dosage technology firm is having a record year after being divested by Pfizer. In an interview, he discusses the firm’s applications for OTC drugs and nutritionals, as well as Capsugel’s international expansion.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.